Home > Boards > US Listed > Biotechs >

ChemoCentryx (CCXI)

Add CCXI Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 7/4/2021 10:37:29 AM - Followers: 29 - Board type: Free - Posts Today: 0

ChemoCentryx is a biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer. The Company targets the chemokine system, a network of molecules, including chemokine ligands and their associated receptors, as well as related chemo-attractant receptors, all of which are known to drive inflammation.

Board of Directors

Thomas J. Schall, Ph.D.President, Chief Executive Officer and Chairman of the Board
Dr. Schall is the founder of our company and has served as our President, Chief Executive Officer and Director since we commenced operations in 1997 and was appointed Chairman of the Board in April 2012. From 1993 to 1997, Dr. Schall worked at the DNAX Research Institute, a division of Schering-Plough Corporation, a pharmaceutical company. Prior to his work at the DNAX Research Institute, he worked as a scientist with Genentech, Inc., a pharmaceutical company. Dr. Schall participated in some of the earliest discoveries of chemokine system function and activities. Dr. Schall cloned one of the first chemokines to be discovered, and provided some of the earliest data for the existence of the previously unknown family of molecules which later came to be called the chemokines. Dr. Schall’s laboratories have been responsible for the discovery or co-discovery of a large percentage of all known chemokine receptors. Dr. Schall received his B.S. in biology from Northern Illinois University and his Ph.D. in cancer biology from Stanford University.

Thomas A. EdwardsRetired Partner, Latham & Watkins, LLP
Thomas A. Edwards has served on our board of directors since July 2015. Until his retirement in March 2014, Mr. Edwards practiced law with Latham & Watkins LLP, an international law firm, since 1983, having become partner in January 1991. His practice focused on general corporate and securities law, including capital financings, acquisitions, divestitures and spin-offs of companies and partnerships. Mr. Edwards earned his bachelor’s degree from Harvard College and his law degree from Harvard Law School.

Joseph M. Feczko, M.D.Former Senior Vice President and Chief Medical Officer, Pfizer Inc.
Dr. Feczko has served on our board of directors since April 2012. Until his retirement in May 2009, Dr. Feczko was Senior Vice President and Chief Medical Officer of Pfizer Inc. and a member of its Executive Leadership Team with global responsibilities for all aspects of the company’s medical, regulatory and safety activities. Dr. Feczko served Pfizer in both New York and the United Kingdom since 1982, where he held positions of increasing responsibility in clinical research and regulatory affairs and safety, culminating in the role of Chief Medical Officer. Dr. Feczko is board-certified in Internal Medicine and Infectious Diseases. He has a B.S. degree from Loyola University Chicago, and an M.D. from the University of Illinois College of Medicine. Dr. Feczko also serves on the board of directors of Keryx Biopharmaceuticals, Inc. and Cytheris, SA. Dr. Feczko also serves as chairman of the board of directors of Cardoz Pharmaceuticals AB (Stockholm, Sweden) and as a member of the Supervisory Board of uniQure B.V., based in the Netherlands.

Roger C. Lucas, Ph.D.Vice Chairman, Bio-Techne Corporation
Dr. Lucas has served on our board of directors since September 1997. Since 1995, Dr. Lucas has served as Vice Chairman and a member of the board of directors of Bio-Techne, formerly Techne Corporation, a biotechnology company. From 1985 to 1995, Dr. Lucas served as the Chief Scientific Officer, Senior Executive Vice President and Secretary of Bio-Techne Corporation and the founder of its Biotechnology Division. Prior to this, Dr. Lucas was Vice President of Research at R&D Systems, now a subsidiary of Bio-Techne, where he worked for over ten years. Dr. Lucas received his B.S. in biology and chemistry from St. Mary’s College, Minnesota and his Ph.D. in physiology and cell biology from Illinois Institute of Technology. Dr. Lucas also presently serves on the board of directors of a number of privately held companies.

Geoffrey M. ParkerFormer Executive Vice President and Chief Financial Officer, Anacor Pharmaceuticals, Inc.
Mr. Parker has served on our board of directors since December 2009. From September 2010 to May 2015, Mr. Parker was Chief Financial Officer of Anacor Pharmaceuticals, Inc. after serving in a consulting capacity since December 2009. From July 2009 to July 2010, Mr. Parker served in a consulting capacity as the Chief Business Officer of InteKrin Therapeutics, Inc. a biotechnology company and previously served as Managing Director and Partner in the Investment Banking Division of Goldman, Sachs & Co. From 1997 to 2009, Mr. Parker directed Goldman Sachs’ West Region Healthcare Investment Banking practice. From 1995 to 1997, Mr. Parker was Vice President at Feibusch & Co., a venture capital firm. Mr. Parker received his A.B. in Engineering Sciences and Economics from Dartmouth College and his M.B.A. from Stanford University.

James L. TyreeFormer Executive Vice President, Abbott Laboratories
Mr. Tyree has served on our board of directors since June 2012. Mr. Tyree is the co-founder and managing partner of Tyree & D’Angelo Partners, a private equity investment firm. During the last fifteen years, Mr. Tyree has held numerous executive positions at Abbott Laboratories, including Corporate Vice President Pharmaceutical and Nutritional Products Group Business Development, Senior Vice President Global Nutrition and Executive Vice President Global Pharmaceuticals. He retired as President of Abbott Biotechnology Ventures in March 2012. Prior to joining Abbott, Mr. Tyree was the President of SUGEN, Inc., a biotechnology company focused on oncology. Earlier in his career, Mr. Tyree held management positions in Bristol-Myers Squibb, Pfizer and Abbott. Over his entire career, he was a four-time expatriate living and working over six years in Latin America and seven years in Japan. Mr. Tyree is a member of the Advisory Board of the University of Chicago Booth Graduate School of Business, a member of the Chicago Council on Global Affairs and co-chairman of the Global Health Policy Roundtable. Mr. Tyree also serves as a director for a number of privately held companies. Mr. Tyree earned Bachelor’s Degrees in Psychology and Forensic Studies and a Master’s Degree in Business Administration from Indiana University.

Shares outstanding 44.073.659 a/o Aug 2015
Authorized shares 200.000.000
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CCXI News: Chemocentryx: A Risky Yet Potentially Lucrative Bet 07/09/2021 04:31:53 PM
CCXI News: Current Report Filing (8-k) 07/06/2021 10:06:44 AM
CCXI News: ChemoCentryx stock soars 15% after filing an amendment to avacopan NDA; new PDUFA date of October 7 07/06/2021 08:55:47 AM
CCXI News: ChemoCentryx Announces Filing of Amendment to NDA Submission and Extension of the PDUFA Review Period for Avacopan in the Tre... 07/06/2021 08:30:00 AM
CCXI News: Statement of Changes in Beneficial Ownership (4) 06/16/2021 07:02:15 PM
#243   Anything that sends us north is fine by newdmontheblock 07/04/21 10:37:29 AM
#242   I'm thinking we probably get a CONDITIONAL APPROVAL!! chance4 07/04/21 09:19:48 AM
#241   AH looked strong today. Hoping to see some newdmontheblock 07/03/21 01:09:20 AM
#240   Good luck to you as well! newdmontheblock 06/28/21 05:39:21 PM
#239   Initially in at 10.24,and then 12.55.....good luck! Limey42 06/28/21 04:38:20 PM
#238   Hopefully you're watching with some shares in hand! newdmontheblock 06/28/21 03:44:59 PM
#237   Just watching and waiting! Limey42 06/28/21 03:30:32 PM
#236   Surprised this board hasn't been more active lately. newdmontheblock 06/28/21 03:22:32 PM
#235   CCXI CHEMOCENTRYX: A LOT RIDES ON THE APPROVAL avise analytics 06/21/21 08:37:52 AM
#234   I truthfully just got in for the chart...a softballdaddy 06/17/21 01:46:03 PM
#233   lol.. no doubt. I’ve slowly learned to start deadjim 06/17/21 01:41:26 PM
#232   The trick is going in early so you softballdaddy 06/17/21 01:40:17 PM
#231   The deadjim special. The trick is going in deadjim 06/17/21 01:21:48 PM
#230   Ha, saw this chart and I thought of softballdaddy 06/17/21 01:05:51 PM
#229   Gonna have to buy more deadjim 06/11/21 10:09:18 PM
#228   $CCXI is screaming for the top as investors AlphaStockNews 06/11/21 08:44:08 AM
#227   what happens in $CCIX? great movement in the PRE-Opening pennystock_es 06/11/21 08:10:38 AM
#226   Thinking about throwing some $$ on Aug 20 newdmontheblock 06/07/21 07:24:45 PM
#225   >>> ChemoCentryx Announces Results of FDA Advisory Committee gfp927z 06/07/21 04:30:34 PM
#224   >>> ChemoCentryx and VFMCRP Announce Positive Topline Data gfp927z 06/07/21 04:23:07 PM
#223   What's the scoop InkynClyde 05/23/21 04:46:26 PM
#222   Pulled my profits out at my goal level newdmontheblock 05/17/21 01:55:39 PM
#221   Yeah wheeeeeee! Lol bigmike41 05/14/21 03:03:13 PM
#220   * * $CCXI Video Chart 05-10-2021 * * ClayTrader 05/10/21 03:58:05 PM
#219   $CCXI is working to come back after significant AlphaStockNews 05/10/21 09:34:34 AM
#218   Sadly, I’ve gone bearish on CCXI. From all newdmontheblock 05/10/21 02:07:14 AM
#217   SEEKING ALPHA article out about five hours ago DeafTrader2 05/09/21 05:44:27 PM
#216   Took profits at 25.5 so I’m in the newdmontheblock 05/08/21 05:53:24 PM
#215   Should have clarified with a follow up! I newdmontheblock 05/08/21 05:52:30 PM
#214   Hang tight. This will pop back up to JAMISON007 05/08/21 09:11:34 AM
#213   * * $CCXI Video Chart 05-07-2021 * * ClayTrader 05/07/21 05:25:07 PM
#212   You can average down or sit tight. A Cosa 05/07/21 03:00:14 PM
#211   You read my mind! I just bought Cosa 05/07/21 02:54:27 PM
#210   Incredible buying opportunity!!! Termite7 05/07/21 11:00:35 AM
#209   $CCXI: Now $9.60........... You shoulda waited makinezmoney 05/07/21 10:05:40 AM
#208   * * $CCXI Video Chart 05-04-2021 * * ClayTrader 05/04/21 04:33:47 PM
#207   Biggest overreaction I've ever seen. Picked up a newdmontheblock 05/04/21 03:25:16 PM
#206   $CCXI: Getting destroyed today......... down to $18/sh makinezmoney 05/04/21 12:58:37 PM
#205   Exited position today, was looking for a quick Cosa 10/05/20 09:04:14 PM
#204   They just posted a beat on revenues today. Cosa 08/10/20 08:04:33 PM
#203   It's holding and I think more is coming... catchmeifyoucan 12/09/19 07:49:37 PM
#202   This is next..... ALT, just a passing remark catchmeifyoucan 12/04/19 07:44:37 PM
#201   Getting nervous could drop today damondon 11/29/19 06:50:23 AM
#200   * * $CCXI Video Chart 11-26-2019 * * ClayTrader 11/26/19 04:39:19 PM
#199   CCXI did it. Once of my many biotech's cjstocksup 11/26/19 10:32:57 AM
#198   I sold half after hours in case if Glider549 11/26/19 09:46:29 AM
#197   PT raised to $56 vs. $17 at crudeoil24 11/26/19 09:15:11 AM
#196   CCXI up 325% @ 34.32 > VFMCRP and crudeoil24 11/26/19 09:12:54 AM
#195   Congrats to all those that stuck with CCXI Whalatane 11/26/19 08:40:21 AM
#194   Alerted entry at $8, only thing they were Zmill 11/25/19 11:29:43 PM
Consent Preferences